Topic: artificial intelligence
Charles River teams with Atomwise in an effort to streamline research efforts to speed drugs to market.
GE Healthcare and Vanderbilt University are developing diagnostics that use AI to predict both efficacy and side effects of cancer immunotherapies.
We certainly like to offer a full breakfast here at FierceBiotech, especially at the J.P. Morgan Healthcare Conference here in San Francisco.
Sophia Genetics raised $77 million in new venture capital to help fund its expansion to its new U.S. location and bring on more staff.
Owkin has unveiled what it calls the world’s largest network for artificial intelligence-based medical research, with data from over 40 institutions.
Gritstone Oncology has appointed Jonah Rainey, Ph.D., to head up its bispecific antibody program as it moves into lead optimization.
Merck KGaA has licensed a cloud-based artificial intelligence proteome screening platform from the Toronto-based Cyclica.
The FDA granted Bayer and Merck breakthrough device status for AI-based software that spots a rare form of pulmonary hypertension in CT scans.
Medtronic plans to absorb Nutrino Health, a nutrition-focused data analytics company, and further integrate its work with its diabetes group.
U.K.-based CRO Fusion Antibodies is partnering with Analytics Engines.